| |
4-6 months follow- |
6-12 months follow- |
>12 months |
P Value |
| |
up group |
up group |
follow-up group |
|
| Feature |
(n=26) |
(n=45) |
(n=34) |
|
| Age |
66 ± 11.5 |
67 ± 14.0 |
70 ± 12.3 |
0.437 |
| Gender |
15% male, |
36% male, |
26% male, |
0.184 |
| |
85% female |
64% female |
74% female |
|
| Bilateral |
0 |
0 |
1 |
--- |
| VAS Before Diagnostic |
8.52 ± 1.07 |
8.07 ± 1.11 |
7.99 ± 1.44 |
0.209 |
| Block |
|
|
|
|
| VAS After Diagnostic |
1.21 ± 1.38 |
1.42 ± 1.28 |
2.10 ± 1.40 |
0.025 |
| Block |
|
|
|
|
| VAS at 3-4 Weeks After |
1.59 ± 1.44 |
1.50 ± 1.86 |
1.69 ± 1.76 |
0.898 |
| Treatment (n=97) |
(n=24) |
(n=42) |
(n=31) |
|
| Surgery before study |
92% none; |
64% none; |
77% none; |
0.032 |
| |
8% not defined; |
19% not defined; |
23% not defined; |
|
| |
0% intervention |
17% intervention |
0% intervention |
|
| |
with artificial |
with artificial |
with artificial |
|
| |
implants |
implants |
implants |
|
|
